Palo Alto, California (PressExposure) December 21, 2009 -- MetricStream, Inc., the market leader in enterprise-wide Governance, Risk, Compliance (GRC) and Quality Management solutions, today announced that Kendle International Inc. (NASDAQ: KNDL), a leading global clinical research organization (CRO), has selected the MetricStream platform and solution for compliance and quality management, automating and streamlining its auditing and corrective action/preventive action (CAPA) processes.
As one of the worldâs largest global providers of Phase I-IV clinical development services, Kendle is focused on innovative solutions for its clients that reduce cycle times and accelerate the delivery of life-enhancing medicines to market. Tools such as the MetricStream platform enhance Kendleâs worldwide, class-leading operational practices, which are designed and executed to ensure compliance with both worldwide regulatory and client requirements.
MetricStreamâs solutions allow organizations such as Kendle to automate the tracking and management of compliance and quality events to ensure that operational activities are continuously measured, monitored and improved upon. As part of Kendleâs commitment to continuous improvement, MetricStream will deploy its advanced, risk-based audit management module to automate and streamline all aspects and functions of Kendleâs Clinical Quality Assurance audit program, from the management of periodic and ad-hoc audit schedules through the tracking of audit observations, findings, recommendations and the resulting audit responses. The MetricStream solution will assist Kendleâs Clinical Quality Assurance auditors in planning and executing audits even more efficiently by providing a powerful, integrated tracking system and workflow engine, automating all steps in the audit lifecycle, including audit scheduling, audit preparation, audit execution, audit report approval, audit report issuance, audit response and any associated corrective action tracking.
In tandem with the MetricStream audit management module, MetricStreamâs CAPA management module will be used to manage the implementation of corrective action/preventive action plans, providing seamless traceability for all related issues and incidents. MetricStream CAPA software will enable Kendle to implement a robust architecture for logging and managing quality issues originating from any source, while its automated workflow engine routes records through all investigation steps, including root cause analysis, CAPA planning, CAPA verification and effectiveness steps.
By providing an enterprise-wide system that can be accessed by all 3,600 Kendle associates across the globe, MetricStreamâs integrated, web-based solution further enhances Kendleâs best-in-class service offerings for the biopharmaceutical industry.
âQuality-of-service and a commitment to continuous improvement continue to distinguish Kendle in the marketplace. Critical initiatives, such as the MetricStream implementation, enhance Kendleâs ability to anticipate and respond to the constantly changing environment in which we operate. Enhancing Kendleâs already robust quality management system with the MetricStream platform will continue to improve cycle times for our clients, as well as reducing regulatory liabilities, risks, and costs for Kendle and our clients,â said Christopher Bergen, Executive Vice President & Chief Administrative Officer.
âWe are pleased to have Kendle as a customer and we look forward to this implementation,â said Carl McCauley, Vice President of Sales at MetricStream. âKendle presents an exciting opportunity for MetricStream. We are thrilled that our platform will play a critical role in further enhancing Kendleâs quality management processes, while at the same time, driving down the cost of compliance for Kendle and its clients.â
About Kendle Kendle International Inc. (Nasdaq: KNDL) is a leading global clinical research organization providing the full range of early- to late-stage clinical development services for the world's biopharmaceutical industry. Our focus is on innovative solutions that reduce cycle times for our customers and accelerate the delivery of life-enhancing drugs to market for the benefit of patients worldwide. As one of the world's largest global providers of Phase I-IV services, Kendle offers experience spanning more than 100 countries, along with industry-leading patient access and retention capabilities and broad therapeutic expertise, to meet our customers' clinical development challenges.
Additional information and investor kits are available upon request from Kendle, 441 Vine Street, Suite 500, Cincinnati, OH 45202 or from the Company's Web site at http://www.kendle.com.